98%
921
2 minutes
20
Background: Photoaging leads to structural changes in the skin, such as reduced collagen production, contributing to wrinkles, reduced elasticity, and dyspigmentation. Collagen-based treatments have shown promise in skin rejuvenation, but the effectiveness of recombinant type III humanized collagen (RhCol-III) solution for injection in Asian populations has not been widely studied.
Aims: To evaluate the efficacy of RhCol-III solution injections in improving skin quality for rejuvenation among Chinese cases.
Methods: Eight Chinese participants with Fitzpatrick phototype III/IV, presenting with signs of skin photoaging, underwent once a month intradermal injections of 2 mg/mL RhCol-III solution over a 90-day period. Clinical assessments, including VISIA imaging, ultrasound, cutometer, and self-assessed Global Aesthetic Improvement Scale (GAIS) scores, were conducted at baseline, 30, 60, and 90 days postinjection. Key skin parameters such as elasticity, firmness, wrinkle severity, pigmentation, and pore size were evaluated to assess the effectiveness of the RhCol-III solution.
Results: Participants demonstrated significant improvements in skin quality, although variable due to individual response. VISIA imaging indicated enhanced skin tone evenness and radiance. Participants who had visible wrinkle reduction and pore size decrease, on further assessment, were found to have increased dermal thickness and density, along with improved skin elasticity and firmness. Most participants reported high levels of satisfaction with the treatment outcomes, and no significant adverse events were observed.
Conclusions: RhCol-III solution injections appear to be a safe and effective treatment for skin rejuvenation, offering improvements in elasticity, firmness, skin tone, and radiance. This case series brings out the potential of RhCol-III solution in providing substantial anti-photoaging benefits in Chinese facial skin.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12278026 | PMC |
http://dx.doi.org/10.1111/jocd.70276 | DOI Listing |
J Cosmet Dermatol
July 2025
Department of Plastic Surgery, JingRen Clinic, Shanghai, China.
Background: Photoaging leads to structural changes in the skin, such as reduced collagen production, contributing to wrinkles, reduced elasticity, and dyspigmentation. Collagen-based treatments have shown promise in skin rejuvenation, but the effectiveness of recombinant type III humanized collagen (RhCol-III) solution for injection in Asian populations has not been widely studied.
Aims: To evaluate the efficacy of RhCol-III solution injections in improving skin quality for rejuvenation among Chinese cases.
J Cosmet Dermatol
May 2025
Department of Plastic Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Background: Facial erythema and acne scarring are common skin conditions that significantly impair quality of life, necessitating effective treatment options, particularly in Asian populations.
Aims: To evaluate the efficacy and safety of intradermal injections of recombinant type III humanized collagen (RhCol-III) solution for alleviating facial erythema, improving skin texture associated with acne scarring, and evening out skin tone issues associated with post-inflammatory hyperpigmentation (PIH) from acne while also searching for potential underlying anti-inflammatory mechanisms of the RhCol-III solution.
Methods: This case series included six Chinese participants with Fitzpatrick phototypes III/IV, presenting with facial erythema and/or acne scarring.
J Funct Biomater
February 2025
Changzhou Maternity and Child Health Care Hospital, Changzhou 213003, China.
In recent years, factors such as the postponement of childbearing and the relaxation of the childbearing policy have led to an increase in the proportion of cesarean sections and other intrauterine surgeries among pregnant women, further increasing the incidence of uterine scars. Currently, there is a lack of effective clinical treatment methods for uterine scars. In this study, a suture loaded with gene medicine was designed for the repair of uterine scars.
View Article and Find Full Text PDFJ Control Release
January 2024
National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Chuanda-Jinbo Joint Research Center, Sichuan University, Chengdu 610064, People's Republic of China.
Myocardial infarction (MI) has become the primary cause of cardiovascular mortality, while the current treatment methods in clinical all have their shortcomings. Injectable biomaterials have emerged as a promising solution for cardiac tissue repair after MI. In this study, we designed a smart multifunctional carrier that could meet the treatment needs of different MI pathological processes by programmatically releasing different therapeutic substances.
View Article and Find Full Text PDFBiomaterials
November 2022
National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Chuanda-Jinbo Joint Research Center, Sichuan University, Chengdu, 610064, People's Republic of China. Electronic address:
Current treatments including drug therapy, medical device implantation, and organ transplantation have considerable shortcomings for myocardial infarction (MI), such as high invasiveness, the scarce number of donor organs, easy thrombosis, immune rejection, and poor therapeutic effects. Therefore, the development of new solutions to repair infarcted hearts is urgently needed. Smart responsive injectable hydrogels have served as a good foundation in biomedical engineering, especially for cardiac regeneration.
View Article and Find Full Text PDF